These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5518686)

  • 1. Screening tests in early diagnosis.
    Ferrer HP
    Ann Soc Belges Med Trop Parasitol Mycol; 1970; 50(4):437-45. PubMed ID: 5518686
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating validity of screening tests.
    Larson E
    Nurs Res; 1986; 35(3):186-8. PubMed ID: 3635057
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer screening--benefits, harms and making an informed choice.
    Barratt AL
    Aust Fam Physician; 2006; 35(1-2):39-42. PubMed ID: 16489385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Decreasing women's anxieties after abnormal mammograms: a controlled trial.
    Kopans DB
    J Natl Cancer Inst; 2004 Aug; 96(15):1186-7; author reply 1187. PubMed ID: 15292393
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosing tests: using and misusing diagnostic and screening tests.
    Streiner DL
    J Pers Assess; 2003 Dec; 81(3):209-19. PubMed ID: 14638445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer screening: medico-legal aspects].
    Buzzi F
    Ann Ig; 2003; 15(1):3-10. PubMed ID: 12666320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen section diagnosis: accuracy and errors; uses and abuses.
    Saltzstein SL; Nahum AM
    Laryngoscope; 1973 Jul; 83(7):1128-43. PubMed ID: 4719359
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening. What documentation should be required?].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(2):148-52. PubMed ID: 11831074
    [No Abstract]   [Full Text] [Related]  

  • 10. [Screening: an appealing but problematic concept].
    Lagerlund M; Zackrisson S
    Lakartidningen; 2013 Mar 20-26; 110(12):628-30. PubMed ID: 23614209
    [No Abstract]   [Full Text] [Related]  

  • 11. Reporting the assessment of screening and diagnostic tests.
    Wald N; Cuckle H
    Br J Obstet Gynaecol; 1989 Apr; 96(4):389-96. PubMed ID: 2751951
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of early diagnosis in diabetes].
    Basler HD; Collatz J; Keil U; Mitzkat HJ; Pflanz M; Schaefer M; Schwoon D
    Dtsch Med Wochenschr; 1972 Sep; 97(38):1437-8. PubMed ID: 5071756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity and specificity of diagnostic tests].
    Marchi F
    G Ital Cardiol; 1981; 11(3):293-6. PubMed ID: 7286506
    [No Abstract]   [Full Text] [Related]  

  • 14. Can you handle the truth (and know it when you see it)? Understanding sensitivity, specificity, predictive values, and ROC curves.
    Cotter K; Peipert JF
    J Minim Invasive Gynecol; 2005; 12(5):385-90. PubMed ID: 16213422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External quality control of cervical cytopathology: interlaboratory variability.
    Azara CZ; Manrique EJ; Alves de Souza NL; Rodrigues AR; Tavares SB; Amaral RG
    Acta Cytol; 2013; 57(6):585-90. PubMed ID: 24107687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rapid tests in the office: urine diagnosis].
    Waldherr T
    Fortschr Med; 1977 Feb; 95(5):284-6. PubMed ID: 838447
    [No Abstract]   [Full Text] [Related]  

  • 17. WHO recommends against inaccurate tuberculosis tests.
    Morris K
    Lancet; 2011 Jan; 377(9760):113-4. PubMed ID: 21226229
    [No Abstract]   [Full Text] [Related]  

  • 18. [Roaming through methodology. XXXII. False test results].
    van der Weijden T; van den Akker M
    Ned Tijdschr Geneeskd; 2001 May; 145(19):906-8. PubMed ID: 11387865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening].
    Durand-Zaleski I; Bastuji-Garin S
    Rev Prat; 2000 May; 50(10):1155-8. PubMed ID: 10905104
    [No Abstract]   [Full Text] [Related]  

  • 20. Problems in the evaluation of screening for disease.
    Wilson JM
    Ann Soc Belges Med Trop Parasitol Mycol; 1970; 50(4):489-503. PubMed ID: 5518692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.